# YAELA
> **ANDA202015** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2014-11-19
## Drug
- **FDA Application Number:** ANDA202015
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** YAELA
- **Generic name:** Drospirenone
- **Active ingredients:** DROSPIRENONE; ETHINYL ESTRADIOL
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **First approval:** 2014-11-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202015)
---
*AI Analytics · CC0 1.0*